theKASID (@theKASID) header
theKASID (@theKASID) profile picture

대한장연구학회

Joined February 2022
Photo by theKASID (@theKASID)Photo by theKASID (@theKASID)Photo by theKASID (@theKASID)Photo by theKASID (@theKASID)Photo by theKASID (@theKASID)Photo by theKASID (@theKASID)Photo by theKASID (@theKASID)Photo by theKASID (@theKASID)Photo by theKASID (@theKASID)Photo by theKASID (@theKASID)
Long-term efficacy and safety of vedolizumab compared with infliximab in biologic-naive ulcerative colitis: a systematic review and meta-analysis doi.org/10.5217/ir.2026.0010…
6
6
475
Hot topic: Step- Up Therapy in Newly Diagnosed Crohn’s Disease: Real-World Trends from Japan doi.org/10.5217/ir.2025.0005…
🤖 Made with AI
1
1
90
Volume 24(3); July 2026 irjournal.org
🤖 Made with AI
1
1
78
Long-term clinical and endoscopic efficacy of vedolizumab and therapeutic persistence in patients with ulcerative colitis in China: a multicenter observational study doi.org/10.5217/ir.2025.0004…
3
3
143
Efficacy and safety of ozanimod in Japanese patients with moderately to severely active ulcerative colitis naive to immunomodulators or advanced therapies: post hoc analysis of the phase 2/3 J-True North study doi.org/10.5217/ir.2026.0003…
1
1
98
Efficacy and safety of ustekinumab in Asian patients with moderately to severely active Crohn’s disease: a small subpopulation analysis of UNITI/IM-UNITI long-term extension through 5 years doi.org/10.5217/ir.2025.0028…
1
2
127
Effectiveness of adjunctive use of antibiotics in acute severe ulcerative colitis: a propensity score matching analysis doi.org/10.5217/ir.2025.0034…
1
2
116
🎉 Intestinal Research has achieved a 2025 Impact Factor of 4.7 and advanced to Q1 in the Gastroenterology & Hepatology category! A heartfelt thank you to our authors, reviewers, editorial board members, and readers for your continued support.
6
14
999
Association between remnant cholesterol and advanced colorectal adenoma in individuals under 50 years of age doi.org/10.5217/ir.2026.0009…
1
1
89
Rapid diagnosis and therapeutic mitigation in inflammatory bowel disease: utilizing the window of opportunity–findings from the UAE Epi-IBD study doi.org/10.5217/ir.2026.0003…
1
2
6
410
Safety of Janus kinase inhibitors compared to biologic therapy in patients with inflammatory bowel disease doi.org/10.5217/ir.2025.0023…
1
4
212
Volume 24(2); April 2026 irjournal.org/
1
2
74
Appropriate J-pouch volume associated with improved clinical outcomes and long-term quality of life in patients with ulcerative colitis after ileal pouch-anal anastomosis: results from China UC Pouch Center Union doi.org/10.5217/ir.2026.0000…
2
4
153
Impact of filgotinib on health-related quality of life over 3 years in Japanese patients with ulcerative colitis: a post hoc analysis of the SELECTION and SELECTION long-term extension trials doi.org/10.5217/ir.2025.0021…
1
1
160
Prospective evaluation of artificial intelligence-assisted monitoring of the effective withdrawal time on adenoma detection doi.org/10.5217/ir.2025.0026…
1
1
130
Analysis of gut microbiota in super donors for fecal microbiota transplantation and isolated gut commensal bacteria of inhibition against Clostridioides difficile doi.org/10.5217/ir.2025.0017…
1
3
119
Association between anti-tumor necrosis factor alpha exposure and new-onset autoimmune diseases in inflammatory bowel disease: a nationwide case-control study in Korea doi.org/10.5217/ir.2025.0019…
1
11
23
1,663
Characteristics of monogenic inflammatory bowel disease in very early-onset cases: a Japanese multicenter registry study doi.org/10.5217/ir.2025.0020…
5
15
661
Temporal hospitalization trends for inflammatory bowel disease in Taiwan doi.org/10.5217/ir.2025.0019…
2
8
263
Safety and effectiveness of budesonide rectal foam for ulcerative colitis in a large-scale, multicenter, prospective observational study: final report of post-marketing surveillance in Japan doi.org/10.5217/ir.2025.0016…
2
5
296